Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

Journal of Clinical Investigation

Volumn 107, Issue 1, 2001, Pages 45-52

  Simantov, Ronit ^a   Febbraio, Maria ^a   Crombie, René ^a   Asch, Adam S ^a   Nachman, Ralph L ^a   Silverstein, Roy L ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; GLYCOPROTEIN; HISTIDINE; THROMBOSPONDIN 1;

ANGIOGENESIS; ARTICLE; CANCER; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR; TUMOR BLOOD FLOW; TUMOR GROWTH;

EID: 0035171206     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9061     Document Type: Article

References (41)

1. Histidine-rich glycoprotein: An abundant plasma protein in search of a function
2. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin
3. Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation
4. Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein
5. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism
6. Complex formation of platelet thrombospondin with histidine-rich glycoprotein
7. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
8. Specific inhibition of endothelial cell proliferation by thrombospondin
9. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
10. Structure of human thrombospondin: Complete amino acid sequence derived from cDNA
11. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro
12. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
13. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
14. Analysis of CD36 binding domains: Ligand specificity controlled by dephosphorylation of an ectodomain
15. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion
16. Identification of a CD36-relared thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: Relationship to HIV-1-specific inhibitory factors in human saliva
17. Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36
18. BEAUTY: An enhanced BLAST-based search tool that integrates multiple biological information resources into sequence similarity search results
19. A space-efficient algorithm for local similarities
20. Assay and purification of naturally occurring inhibitor of angiogenesis
21. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
22. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo
23. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1
24. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
25. Genetic heterogeneity of angiogenesis in mice
26. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats
27. Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a rhrombospondin-1 type 1 repeat
28. Thrombospondin-1 binds to polyhistidine with high affinity and specificity
29. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast
30. Localization of thrombospondin and its cysteine-serine-valine-rhreonine-cysteine-glycine-specific receptor in human breast carcinoma
31. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study
32. Lysosomal integral membrane protein 11 binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif
33. Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1
34. Angiogenic factors
35. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
36. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
37. Antibody blockade of thrombospondin accelerates re-endothelialization and reduces neointima formation in balloon-injured rat carotid artery
38. Histidine-rich glycoprotein is evolutionarily related to the cystatin superfamily. Presence of two cystatin domains in the N-terminal region
39. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein
40. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
41. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma